Amedisys, Inc. (AMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1150169,
    "name": "Amedisys, Inc.",
    "stock_name": "Amedisys, Inc.",
    "full_name": "Amedisys, Inc.",
    "name_url": "stocks-analysis/amedisys-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "100.99",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "100.99",
    "mcapval": "3,307.87",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US0234361089",
    "curr_date": "Aug 15",
    "curr_time": "",
    "bse_nse_vol": "0 ",
    "exc_status": "Active",
    "traded_date": "Aug 15, 2025",
    "traded_date_str": "2025 08 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amedisys-inc-1150169-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Amedisys, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-amedisys-inc-technically-bullish-or-bearish-3545553",
        "imagepath": "",
        "date": "2025-09-20 19:14:03",
        "description": "As of 29 July 2025, the technical trend for Amedisys, Inc. has changed from mildly bullish to bullish. The weekly MACD and Bollinger Bands are bullish, and daily moving averages also indicate a bullish stance. The KST is bullish on both weekly and monthly timeframes, while the OBV shows a mildly bullish trend. However, the RSI indicates no signal on both weekly and monthly charts, and Dow Theory shows no trend in either timeframe. \n\nIn terms of multi-period returns, Amedisys has outperformed the S&P 500 over the past week and month, but it has significantly underperformed over the 1-year, 3-year, and 5-year periods. Overall, the current technical stance is bullish, supported by strong indicators, but the long-term performance remains a concern...."
      },
      {
        "title": "Is Amedisys, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-amedisys-inc-overvalued-or-undervalued-3542252",
        "imagepath": "",
        "date": "2025-09-20 17:48:27",
        "description": "As of 14 August 2025, the valuation grade for Amedisys, Inc. has moved from expensive to very expensive, indicating a significant shift in its valuation outlook. The company appears overvalued, with a P/E ratio of 20, compared to a peer average P/E of approximately 17.89, and an EV to EBITDA ratio of 15.03, which is higher than the industry average. Additionally, the PEG ratio stands at a notably low 0.30, suggesting that the stock may not be justified at its current price given its growth prospects.\n\nIn comparison to its peers, Encompass Health Corp. has a P/E of 20.94 and The Ensign Group, Inc. shows a much higher P/E of 32.46, both indicating that Amedisys is trading at a premium relative to these companies. Furthermore, Amedisys's recent stock performance has lagged behind the S&P 500, with a 1-year return of 2.58% compared to the index's 17.14%, and a staggering 5-year return of -56.15% versus the S&P'..."
      }
    ],
    "total": 7,
    "sid": "1150169",
    "stock_news_url": "https://www.marketsmojo.com/news/amedisys-inc-1150169"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Amedisys, Inc. technically bullish or bearish?

2025-09-20 19:14:03

As of 29 July 2025, the technical trend for Amedisys, Inc. has changed from mildly bullish to bullish. The weekly MACD and Bollinger Bands are bullish, and daily moving averages also indicate a bullish stance. The KST is bullish on both weekly and monthly timeframes, while the OBV shows a mildly bullish trend. However, the RSI indicates no signal on both weekly and monthly charts, and Dow Theory shows no trend in either timeframe. In terms of multi-period returns, Amedisys has outperformed the S&P 500 over the past week and month, but it has significantly underperformed over the 1-year, 3-year, and 5-year periods. Overall, the current technical stance is bullish, supported by strong indicators, but the long-term performance remains a concern....

Is Amedisys, Inc. overvalued or undervalued?

2025-09-20 17:48:27

As of 14 August 2025, the valuation grade for Amedisys, Inc. has moved from expensive to very expensive, indicating a significant shift in its valuation outlook. The company appears overvalued, with a P/E ratio of 20, compared to a peer average P/E of approximately 17.89, and an EV to EBITDA ratio of 15.03, which is higher than the industry average. Additionally, the PEG ratio stands at a notably low 0.30, suggesting that the stock may not be justified at its current price given its growth prospects. In comparison to its peers, Encompass Health Corp. has a P/E of 20.94 and The Ensign Group, Inc. shows a much higher P/E of 32.46, both indicating that Amedisys is trading at a premium relative to these companies. Furthermore, Amedisys's recent stock performance has lagged behind the S&P 500, with a 1-year return of 2.58% compared to the index's 17.14%, and a staggering 5-year return of -56.15% versus the S&P'...

View All News